V900548
TWEEN® 20
Vetec™, reagent grade, 40%
Synonym(s):
Polyethylene glycol sorbitan monolaurate, Polyoxyethylenesorbitan monolaurate
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
grade
reagent grade
description
non-ionic detergent
product line
Vetec™
assay
≥40%
form
viscous liquid
concentration
40%
technique(s)
DNA extraction: suitable, RNA extraction: suitable, cell culture | mammalian: suitable, protein purification: suitable
refractive index
n20/D 1.468 (lit.)
viscosity
400 mPa.s(25 °C)
mp
98.9 °C
solubility
water: 0.0002 g/L at 20 °C
Application
Non-ionic detergent
Legal Information
TWEEN is a registered trademark of Croda International PLC
Vetec is a trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under TWEEN® 20
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
>298.4 °F - closed cup
flash_point_c
> 148 °C - closed cup
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Deng Pan et al.
Experimental brain research, 238(4), 1085-1095 (2020-03-28)
Ghrelin is an orexigenic agonist that acts directly on neurons in the hypothalamus, controlling appetite and energy balance. Although its role in appetite-associated neurons has been described, the relationship between peripheral ghrelin stimulation and oxytocin expression in the paraventricular nucleus
Julie Beegle et al.
Stem cells (Dayton, Ohio), 33(6), 1818-1828 (2015-02-24)
Mesenchymal stem cells/multipotent stromal cells (MSCs) are promising therapeutics for a variety of conditions. However, after transplantation, cell retention remains extremely challenging. Given that many hypoxic signals are transitory and that the therapeutic administration of MSCs is typically into tissues
Daniel C Zielinski et al.
Nature communications, 6, 7101-7101 (2015-06-10)
Drug side effects cause a significant clinical and economic burden. However, mechanisms of drug action underlying side effect pathogenesis remain largely unknown. Here, we integrate pharmacogenomic and clinical data with a human metabolic network and find that non-pharmacokinetic metabolic pathways
Global Trade Item Number
| SKU | GTIN |
|---|---|
| V900548-100ML | 04061838176462 |
| V900548-500ML | 04061838260505 |